Pipeline and Commercial Insight: Schizophrenia - Second Generation Depots Protect Market Value - Market Research Reports

Welcome - Home - Register - Login - Help/FAQ - 0 items

Search
Enter keywords, a title or
a report id number below.

Advanced


	Select a currency for use throughout the site

Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying

| More

Electronic (PDF)
Enterprisewide

Pipeline and Commercial Insight: Schizophrenia - Second Generation Depots Protect Market Value
Datamonitor, Oct 2008, Pages: 277



		Description



		Table of Contents



		Enquire before Buying


	Send to a Friend

Send to a Friend

To email a friend details of Pipeline and Commercial Insight: Schizophrenia - Second Generation Depots Protect Market Value complete the form below and click on "Send".

* Required Information

Your Friend's Details

Friend's Full Name *

Friend's Email Address *

A message for your Friend

Your Contact Details

Your Name *

Email Address *

Customers who bought this item also bought

Pipeline Insight: Schizophrenia

CNS Drug Discoveries: Schizophrenia Chapter

Schizophrenia Market: Novel Agents May Establish New Leaders

Central Nervous System Schizophrenia

Treatment Algorithms 2001: Schizophrenia - The Rise of Atypical Neuroleptics as the Physicians’ Favorite

Pipeline Report - Neuronal alpha 7 nicotinic receptors: Candidates for the treatment of Alzheimers disease and Schizophrenia

CNS Generic Drugs: Prospects and Opportunities to 2012

Generic Drugs Market in Brazil (2007-2011)

Opportunities and Challenges for Bioequivalent Generic Drugs in Brazil

Pipeline Insight: Antipsychotics - Novel Antipsychotics Driving Market Evolution

Drugs of Tomorrow: Antipsychotics - Gaining Competitive Advantage From a Limited Research Base

Pipeline Insight: Neuropathic Pain - Emerging Drugs Fail to Capitalize in Lucrative Market

Top of page